clinical research



poster sessions


New research on the use of psychedelic drugs as treatment for a range of mental disorders appears to be throwing open doors of perception long closed within the medical community.
Los Angeles Times, September 2015

Discover the latest research into the benefits and risks of psychedelics and marijuana for psychotherapy, neuroscience, spirituality, and creativity, and more.

The Three-Day Conference (April 21-23) will feature three simultaneous tracks of presentations by leading and up-and-coming international researchers in the multidisciplinary field of psychedelic science and medicine. Presenters from around the world will share recently completed and ongoing research into the therapeutic, scientific, and spiritual uses of:

  • MDMA
  • LSD
  • Ayahuasca
  • Psilocybin
  • Ibogaine
  • Ketamine
  • Peyote
  • Medical marijuana
...and much more!

Clinical Research Track

Rick Doblin, Ph.D.
The Future of Psychedelic Therapy



Roland Griffiths, Ph.D.
Johns Hopkins Psilocybin Research Project: Studies of Mystical Experience, Adverse Effects, Meditation in Healthy Volunteers, and Palliative Effects in Cancer Patients


Stan Grof, M.D.
The Implications of Consciousness Research for Psychiatry, Psychology, and Psychotherapy


Amanda Feilding
Breakthroughs in Psychedelic Research from the Beckley Foundation






David Nichols, Ph.D.
Psychedelic Neuroscience


David Nutt, M.D.
Psychedelic Research at the Beckley/Imperial Research Programme






Interdisciplinary Research Track





James Fadiman, Ph.D., and Sophia Korb, Ph.D.
Preliminary Results from Psychedelic Microdosing Study




Katherine Hendy, Ph.D.
The Placebo Paradox



Ethan Nadelmann, Ph.D.
Drug Policy and Psychedelics







Paul Stamets
Mushroom Mycology







Plant Medicine Track

Organized by Bia Labate, Ph.D.










alexander dawson headshot

Alexander Dawson, Ph.D.
Peyote's Race Problem












o hayden griffin

O. Hayden Griffin, III, Ph.D.
The Therapeutic Potential of Kratom

























graham st john

Graham St. John, Ph.D.
DMT, Liminality, and Hyperspace






Share This Page